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  GENERAL ORTHOPAEDICS
Catching the second wave: clinical 
characteristics and nosocomial infection 
rates in major trauma and orthopaedic 
patients during the COVID-19 pandemic
Aims
The new COVID-19 variant was reported by the authorities of the UK to the World Health 
Organization (WHO) on 14 December 2020. We aim to describe the clinical characteristics 
and nosocomial infection rates in major trauma and orthopaedic patients comparing the 
first and second wave of COVID-19 infection.
Methods
A retrospective analysis of a prospectively collected trauma database was reviewed at a 
level 1 major trauma centre from 1 December 2020 to 18 February 2021 looking at demo-
graphics, clinical characteristics, and nosocomial infections and compared to our previ-
ously published first wave data (26 January 2020 to 14 April 2020).
Results
From 1 December 2020 to 18 February 2021, 522 major trauma patients were identified 
with a mean age of 54.6 years, and 53.4% (n = 279) were male. Common admissions 
were falls (318; 60.9%) and road traffic accidents (RTAs; 71 (13.6%); 262 of these patients 
(50.2%) had surgery. In all, 75 patients (14.4%) tested positive for COVID-19, of which 
51 (68%) were nosocomial. Surgery on COVID-19 patients increased to 46 (61.3%) in the 
second wave compared to 13 (33.3%) in the first wave (p = 0.005). ICU admissions of pa-
tients with COVID-19 infection increased from two (5.1%) to 16 (20.5%), respectively (p = 
0.024). Second wave mortality was 6.1% (n = 32) compared to first wave of 4.7% (n = 31). 
Cardiovascular (CV) disease (35.9%; n = 14); p = 0.027) and dementia (17.9%; n = 7); p 
= 0.030) were less in second wave than the first. Overall, 13 patients (25.5%) were Black, 
Asian and Minority ethnic (BAME), and five (9.8%) had a BMI > 30 kg/m2. The mean time 
from admission to diagnosis of COVID-19 was 13.9 days (3 to 44). Overall, 12/75 (16%) of 
all COVID-19 patients died.
Conclusion
During the second wave, COVID-19 infected three- times more patients. There were dou-
ble the number of operative cases, and quadruple the cases of ICU admissions. The pa-
tients were younger with less dementia and CV disease with lower mortality. Concomitant 
COVID-19 and the necessity of major trauma surgery showed 13% mortality in the second 
wave compared with 15.4% in the first wave. In contrast to the literature, we showed a 
high percentage of nosocomial infection, normal BMI, and limited BAME infections.
Cite this article: Bone Jt Open 2021;2-8:661–670.
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Introduction
On 13 December 2020, a total of 1,108 
cases infected with Severe Acute Respira-
tory Syndrome Coronavirus 2 (SARS- CoV-2) 
VUI 202012/01 (variant under investigation 
(VUI), year 2020, month 12, variant 01) 
were reported.1 On 14 December 2020, the 
UK authorities reported this to the World 
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Health Organization (WHO), indicating the variant may 
be more easily spread between people.
Due to a sudden rise in COVID-19 cases in South 
East England, an epidemiological and virological inves-
tigation was initiated in early December 2020, which 
resulted in the discovery of the new variant. On 29 
December 2020, there were about 79 million confirmed 
cases of COVID-19, with approximately 1.7 million fatal-
ities globally.2
Following the first wave, elective surgery was 
suspended, with emergency and trauma surgery 
continuing3 in order to reduce the spread of the virus and 
impact on resources.4 Trauma admissions at our centre 
(St George's University Hospitals NHS Foundation Trust, 
London, UK) decreased during the first wave, with noso-
comial infections seen in 27/39 patients (69.2%) of those 
with COVID-19.5
Limited evidence on airborne spread led to controver-
sial public health mandates on what was assumed to be 
a virus spread mainly by fomites. Despite mask wearing 
being precedent in Asian countries, many other countries 
did not adopt this policy due to their assumptions that a 
lack of evidence equated to no evidence. During the first 
wave, asymptomatic patients were also assumed to be 
COVID-19 negative on admission.
Evidence has since shown that people who are pre- 
symptomatic or asymptomatic can, in fact, transmit the 
virus to others.6 On 24 June 2020, NHS England issued 
a statement on mandatory patient testing on admission 
to hospital in order to ensure patient safety, maintain 
the public confidence, and protect the wellbeing of NHS 
staff.7
The WHO advised that people maintain a two metre 
interpersonal distance from each other in order to mini-
mize the risk of transmission through droplets from the 
nose and mouth. Recent studies have supported this 
hypothesis of virus transmission from an infected person, 
and also shown that Severe Acute Respiratory Syndrome 
Coronavirus 2 (SARS- CoV-2) has a higher aerosol and 
surface stability compared with SARS- C0V-1, with the 
virus remaining viable and infectious in aerosol for hours.8
On 17 January 2021, data produced by the Univer-
sity of Oxford’s research platform, Our World in Data, 
showed that UK’s COVID-19 death rate was the highest in 
the world, with a mean of 935 daily deaths.9
According to figures from the Office for National Statis-
tics, the second wave of COVID-19 peaked in England 
and Wales on 19 January 2021, with 1,404 deaths in 
one day.10 At the time of the second wave, mandatory 
testing by NHS England of all patients on admission had 
commenced. This therefore gives a true diagnosis of 
nosocomial infection during hospitalization compared to 
our first wave report.5
The aim of this study was to analyze and compare the 
clinical characteristics of patients admitted under major 
trauma and orthopaedics in the first and second waves of 
COVID-19 in order to further elucidate hospital- acquired 
COVID-19 infection rates.
Methods
This single- centre, observational study was designed and 
reported according to STROBE guidance.11 A retrospec-
tive analysis of a prospectively collected trauma database 
was performed at St George's University Hospitals NHS 
Foundation Trust, London, UK. Clinical notes of major 
trauma and orthopaedic patients from 1 December 2020 
to 18 February 2021 were reviewed and compared to our 
previously published first wave data (26 January 2020 to 
14 April 2020).5 SARS- CoV-2 VUI 202012/01 was identi-
fied during this period of the second wave.
Inclusion criteria were all major trauma and ortho-
paedic admissions during this period. Diagnosis of 
COVID-19 was done by the standard nose and throat 
swabbing and laboratory RNA confirmation. All patients 
were swabbed on admission, as per the trust protocol.
Clinical records were analyzed for demographics, mech-
anism of injury (MOI), anatomical pattern of injury, pre- 
morbid state, comorbidities, intervention, BMI, ethnicity, 
COVID-19 status, hospital length of stay (HLOS), and 
mortality. Patients included in this study were contacted 
via telephone for vaccination status, employment status 
(key workers), and previous COVID-19 infection.
Statistical analysis. Following verification of distribution-
al assumptions of normality, groups were compared in 
continuous variables using independent- samples t- test. 
Traditional statistical hypothesis testing with a two- sided 
alternative was employed, with a critical level of signifi-
cance of p < 0.05. No adjustments were made for mul-
tiple hypothesis testing. Analyses were performed using 
SPSS v. 26 (IBM, USA).
Ethical approval. The Health Research Authority (HRA) 
decision tool was used in order to conform to ethical 
approval according to our trust research protocols. The 
study was registered as a service evaluation with the hos-
pital clinical audit department.
Results
Over a one- year period from 1 March 2020 to 28 February 
2021, 3,238 patients were admitted under trauma and 
orthopaedics. In all, 152 patients (4.7%) were COVID-19 
positive. Of these, 111 (73%) were nosocomial infections 
(see Figure 1).
During the first wave between 26 January 2020 to 14 
April 2020, 657 patients were admitted over an 80- day 
period. In contrast, 522 patients were admitted during 
the second wave from 1 December 2020 to 18 February 
2021 over the same time period. There was a decline 
in admissions seen in the first wave, while the second 
wave showed a steady admission rate. Falls and RTA 
remained the most common mechanism of injury with 
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a high incidence of lower and upper limb injuries. In the 
second wave cohort, 75 patients (14.4%) tested positive 
for COVID-19 infection by RNA swab test compared to 39 
(5.9%) in the first wave (p = 0.001). There were 51 (9.8%) 
nosocomial infections in the second wave compared to 
27 (4.1%) in the first wave (p = 0.001). ICU admissions 
were higher in the second wave (56; 10.7%) compared to 
first wave (31; 4.7%) (p = 0.001) (see Table I).
Table  II shows the characteristics of patients with 
COVID-19 comparing the first wave cohort and second 
wave cohort. The mean age group was lower in the 
second wave with 60.1 years (6 to 98) versus 73.2 years 
(28 to 98) in first wave; p < 0.001. There was a similar 
male to female ratio in both waves. First wave patients 
had a higher percentage of comorbidities than second 
wave with hypertension (46.2% vs 35.9%, respectively) 
and cardiovascular (CV) disease (35.9% vs 16.7%, respec-
tively) being the most common.
Surgical intervention was higher in the second wave, 
with 46 patients (61.3%) compared to 13 (33.3%) in first 
wave; p = 0.005. ICU admissions were higher in second 
wave with 16 patients (20.5%) versus two (5.1%) in first 
wave; p = 0.024. The mortality rate was lower in second 
wave (16%) compared to first wave (20.5 %).
Figure  2 shows the different categories of COVID-19 
infection, based on the onset on admission. We define 
hospital acquired COVID-19 infection based on the 
following: hospital- onset hospital- acquired > 14 days 
Fig. 1
Number of admissions, COVID-19 infections, and nosocomial infections of patients admitted on major trauma and orthopaedic wards over a one- year period.
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from sample collection; hospital- onset probable hospital- 
associated > seven days and ≤ 14 days from sample collec-
tion; hospital- onset indeterminate hospital- associated > 
48 hours and ≤ seven days from sample collection; and 
community- onset community- acquired ≤ 48 hours from 
sample collection.
Table III depicts the characteristics of patients admitted 
under trauma and orthopaedics with nosocomial 
COVID-19 infection during the second wave. The mean 
age was 64.8 years (18 to 94) with similar ratio of sex. In 
all, 41 patients (80.4%) were independent prior to admis-
sion; 30 patients (58.8%) had a physical status score 
(ASA) of < 3; 23 patients (45.1%) were of white ethnic 
background, and 25.5% (n = 13) were Black, Asian, and 
minority ethnic (BAME); 20 patients (39.2%) had a BMI of 
between 18.5 kg/m2 and 24.9 kg/m2, with two patients 
(4%) having a BMI < 18.5 kg/m2 and 10% (n = 5) haivng 
a BMI > 30 kg/m2.
The mean LOS from diagnosis of COVID-19 infection 
was 13.9 days (3 to 44). No patients had COVID-19 infec-
tion prior to admission, and no patients had the vaccine 
at the time of this study. In total, one patient (2%) was a 
key worker.
Table  IV shows the characteristics of hip fracture 
patients with COVID-19 infection in the second wave 
cohort. The mean age group was 80.6 years (55 to 98), 
with a male to female ratio of 10:6. Overall, 13 (81.2%) 
Table I. Population characteristics comparing the first and second waves 
of COVID-19.
Variable
First wave, n 
= 657
Second wave,
n = 522 p- value
Mean age, yrs, (range) 55.3 (8 to 98) 54.6 (0 to 98) 0.613
Age, yrs, n (%)
< 60 362 (55.1) 283 (54.2) 0.762
> 60 295 (44.9) 236 (45.2) 0.915
Sex, n (%)
Male 393 (59.8) 279 (53.4) 0.028*
Female 264 (40.2) 243 (46.6) 0.028*
Admission type, n (%)
Trauma 344 (52.4) 161 (30.8) < 0.001*
Orthopaedic 313 (47.6) 361 (69.2) < 0.001*
Mechanism of injury, n 
(%)
Fall 351 (53.4) 318 (60.9) 0.010*
Road traffic accident 107 (16.3) 71 (13.6) 0.201
Assault 45 (6.8) 33 (6.3) 0.717
Pain 54 (8.2) 24 (4.6) 0.013*
Self- harm 24 (3.7) 12 (2.3) 0.179
Wound infection 17 (2.6) 23 (4.4) 0.087
Accidental 14 (2.1) 0 (0) < 0.001*
Sport 11 (1.7) 3 (0.6) 0.083
Malignancy 3 (0.5) 7 (1.3) 0.100
Twisting 6 (0.9) 1 (0.2) 0.109
Other 25 (3.8) 30 (5.7) 0.116
Injury anatomy, n (%)
Lower limb 173 (26.3) 157 (30.1) 0.155
Upper limb 162 (24.7) 123 (23.6) 0.663
Thorax and abdomen 138 (21.0) 70 (13.4) < 0.001*
Pelvic 118 (18.0) 105 (20.1) 0.348
Head and neck 112 (17.0) 82 (15.7) 0.538
Spine 88 (13.4) 75 (14.4) 0.630
Intervention, n (%)
Conservative 394 (60.0) 260 (49.8) < 0.001*
Surgical 263 (40.0) 262 (50.2) < 0.001*
COVID-19 positive, n (%)
Community infection 12 (1.8) 24 (4.6) 0.006*
Nosocomial infection 27 (4.1) 51 (9.8) < 0.001*
Total infection 39 (5.9) 75 (14.4) < 0.001*
ICU admissions 31 (4.7) 56 (10.7) < 0.001*
Mortality 31 (4.7) 32 (6.1) 0.284
*The test statistics are for the null hypothesis significance test for the 
comparison of first wave with second wave. Independent- samples t- test 
was conducted. Statsitically significant.
ICU, intensive care unit.






n = 75 p- value
Age, yrs
Mean (range) 73.2 (28 to 98) 60.1 (6 to 98) < 0.001*
< 60, n (%) 7 (17.9) 34 (45.3) < 0.001*
> 60, n (%) 32 (82.1) 41 (54.7) < 0.001*
Sex, n (%)
Male 22 (56.4) 38 (50.7) 0.560
Female 17 (43.6) 37 (49.3) 0.560
Comorbidity, n (%)
Hypertension 18 (46.2) 28 (35.9) 0.362
Cardiovascular disease 14 (35.9) 13 (16.7) 0.027*
Arthritis 9 (23.1) 3 (3.8) < 0.001*
Diabetes 8 (20.5) 10 (12.8) 0.319
Dementia 7 (17.9) 4 (5.1) 0.030*
Malignancy 6 (15.4) 7 (9.0) 0.335
COPD 4 (10.3) 4 (5.1) 0.329
Kidney disease 4 (10.3) 13 (16.7) 0.314
Asthma 2 (5.1) 8 (10.3) 0.321
Intervention, n (%)
Conservative 26 (66.7) 29 (38.7) 0.005*
Surgical 13 (33.3) 46 (61.3) 0.005*
Onset of infection, 
n (%)
Community infection 12 (30.8) 24 (32) 0.893
Nosocomial infection 27 (69.2) 51 (68) 0.893
Intensive care unit
Admissions, n (%) 2 (5.1) 16 (20.5) 0.024*
Average LOS, days 
(range)
4 (2 to 6) 6.9 (1 to 47) 0.030*
Mortality, n (%) 8 (20.5) 12 (16) 0.548
Surgical mortality, 
n (%)
2 (15.4) 6 (13) 0.569
*The test statistics are for the null hypothesis significance test for the 
comparison of first wave with second wave. Independent- sample t- test 
was conducted. *Statsitically significant.
COPD, chronic obstructive pulmonary disease; LOS, length of stay.
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were nosocomial infections with an average LOS from 
admission to diagnosis of 9.9 days (3 to 26). The mortality 
rate was 12.5% (n = 2).
Table  V depicts clinical characteristics of 12 patients 
with COVID-19 infection who died. In all, 8/12 (66.7%) 
were nosocomial infections. These patients were over the 
age of 60 years, with six (50%) having surgery, and four 
(33.3%) with ICU admission. The mean HLOS was 19.8 
days (2 to 71).
Discussion
This study compares series of patients’ clinical character-
istics and outcomes of nosocomial COVID-19 infection 
during their admission on major trauma and orthopaedic 
wards during the first and second wave. We chose this 
time frame for the second wave as it represents the time 
the new variant SARS- CoV-2 VUI 202012/01 (variant 
under investigation (VUI), year 2020, month 12, variant 
01) was identified.
There were fewer admissions during the second 
wave (n = 522) over the same amount of days (80 days) 
compared to the first wave (n = 657). Trauma admis-
sions were significantly higher (p < 0.001) in the first 
wave (53.4%) compared to 30.8% in the second wave. 
A contributing factor to fewer admissions could be 
due to the holiday season. Furthermore, the first wave 
reflects pre- COVID-19 and pre- lockdown admission, 
while public comprehension had led to improved public 
health compliance by the second wave.12 Falls and RTAs 
remained the most common MOI in both waves. There 
was approximately three- times the COVID-19 patients in 
Fig. 2
Number of days between admission and positive COVID-19 infection.
Table III. Characteristics of nosocomial COVID-19 patients.
Variable Nosocomial (n = 51)
Age, yrs, mean (range) 64.8 (18 to 94)
Sex, male:female 25:26
Pre- morbid state, n (%)
Independent 41 (80.4)
Supported housing 2 (3.9)
Family support 4 (7.8)
Home carer 4 (7.8)









BMI, kg/m2, n (%)
< 18.5 2 (3.9)
18.5 to 24.9 20 (39.2)
25 to 29.9 18 (35.3)
> 30 5 (9.8)
Unrecorded 6 (11.8)
Employment status, n (%)
Key worker 1 (2)
Mean LOS from admission to diagnosis, 
days (range)
13.9 (3 to 44)
Prior COVID-19 infection, n 0
Vaccination, n 0
*There was a 100% telephone response rate.
ASA, American Society of Anaesthesiologists physical status classification 
system; LOS, length of stay.
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major trauma in the second wave compared to the first 
(14.4% vs 5.9%).
Traumatically injured patients requiring hospital 
admission are a unique cohort of relatively well and 
usually non- COVID-19 infected people. This represents 
the normal population forced to use hospital services at a 
time when public health messages encourage avoidance 
of hospitals. Surgery may be a risk factor for COVID-19 
infection. The incidence of surgery across all patients in 
the second wave was significantly higher (p < 0.001) at 
50.2% (n = 262) compared to 40% (n = 263) in the first 
wave.
There was approximately double the number of 
COVID-19 patients undergoing surgery in the second 
wave cohort, with 13 (33.3%) in the first wave cohort 
versus 46 (61.3%) in the second (p = 0.005). This finding 
may be influenced by findings by Lei et al,13 who studied 
34 operative patients in Wuhan, China, and suggests 
that surgery may have accelerated and exacerbated the 
disease progression due to patients developing symp-
toms shortly after surgery.
Regardless of COVID-19 infection, there were almost 
double the ICU admissions in the second wave (n = 56; 
10.7%) versus the first wave (n = 31; 4.7%)(p < 0.001). 
Both waves had a similar male to female ratio of COVID-19 
infection in contrast to other studies that have reported 
males being at higher risk.14,15
The new variant of COVID-19 is reported to be more 
infectious and virulent,16 and is highlighted by several of 
our results. First, there were three- fold more COVID-19 
infections, and second, there was significant increase in 
COVID-19 patients admitted to ICU in the second wave 
(n = 16; 20.5%) compared to the first wave (n = 2; 5.1%) 
(p = 0.024).
Similar comorbidities, including hypertension, CV 
disease, kidney disease, diabetes, and arthritis, were seen 
in both waves, with patients in the first wave having a 
significantly higher number than the second wave: CV 
disease (n = 14 (35.9%) vs n = 13 (16.7%) (p = 0.027); 
dementia (n = 7 (17.9%) vs n = 4 (5.1%) (p = 0.030); and 
arthritis (n = 9 (23.1%) vs n = 3 (3.8%) (p < 0.001).
In support of the more virulent strain, patients with 
COVID-19 infection were significantly younger (p < 
0.001) in the second wave (mean 60.1 years; 6 to 98) 
compared to 73.2 years (28 to 98) in the first wave. We 
demonstrated that no children were discovered with 
COVID-19 in the first wave, but there were infections of 
children in the second wave, with one (1.3%) aged nine 
years or younger, and one (1.3%) aged between ten and 
19 years. Reports now show that the COVID-19 does 
occur in children, but infections are milder or asymptom-
atic, with a better prognosis than adults.17
We did not show a high prevalence of increased BMI in 
our patients. Among the nosocomial COVID-19 patients 
in the second wave, only six (11.8%) had a BMI greater 
than 30 kg/m2. We also did not show a high prevalence 
of ethnic minority infections, where only 44.9% of the 
London, UK, population is white British.18 Interestingly, 
25.5% of our COVID-19 cohort (n = 13) were of the BAME 
population. Our results are noteworthy because they 
differ from other reports that have shown that BAME 
ethnicity and higher BMI were independently associated 
with the greater odds of COVID-19.15,19
Table IV. Characteristics of COVID-19 hip patients in the second wave.
Variable Hip fractures (n = 16)
Mean age, yrs (range) 80.6 (55 to 98)
Sex, male: female 10:5
Mechanism of injury, n (%)
Fall 13 (81.2)




Cardiovascular disease 7 (43.8)
Kidney disease 5 (31.3)
Dementia 1 (6.3)
Type of surgery, n (%)
Hemi 6 (37.5)
Dynamic hip screw 4 (25)
Intramedullary nail 5 (31.3)
Washout 1 (6.3)
Onset of infection, n (%)
Community infection 3 (18.8)
Nosocomial infection 13 (81.2)
Mean LOS from admission to diagnosis of 
hospital associated infection, days (range)
9.9 (3 to 26)
Pre- morbid state, n (%)
Independent 11 (68.8)
Supported housing 2 (12.5)
Home carer 3 (18.8)









BMI, kg/m2 n (%)
< 18.5 1 (6.3)
18.5 to 24.9 5 (31.3)
25 to 29.9 5 (31.3)
> 30 0 (0.0)
Unrecorded 5 (31.3)
Intensive care unit, n (%)
Admission 3 (18.8)
Mean LOS, days (range) 3.5 (2 to 5)
Mortality, n (%) 2 (12.5)
ASA, American Society of Anaesthesiologists; DHS, dynamic hip screw; 
Hemi, hemiarthroplasty; IM nail, intramedullary nail; LOS, length of stay; 
MOI, mechanism of injury.
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Table V. Clinical characteristics of 12 patients who died with COVID-19 infection.
Variable Patient 1 Patient 2 Patient 3 Patient 4 Patient 5 Patient 6
DOA 08/12/2020 04/12/2020 07/01/2021 10/12/2020 14/12/2020 01/12/2020
Age, yrs 66 83 67 71 66 65
Sex, male/female Male Female Male Male Female Female
Comorbidities
Hypertension Y Y Y N N Y
Cardiovascular disease N Y Y Y N N
Diabetes N N N N N Y
Kidney disease N N Y N N N
Dementia N N N N N N
Arthritis N N N N N N
Admission type
Trauma N N N Y Y Y
Orthopaedics Y Y Y N N N




Head and neck Y N N Y Y N
Thorax Y N N N Y N
Spine N N N N Y N
Pelvic N Y Y N Y N
Upper limn N N N N N Y
Lower limb N N N N N N
Intervention
Surgery N Y Y N Y N
Date of surgery N/A 05/12/2020 08/01/2021 N/A 15/12/2020 N/A
Conservative Y N N Y N Y
BMI, kg/m2 12.46 20.9 22.15 22.6 27.34 47.18
Ethnicity White White Asian Unrecorded White Asian
Pre- morbid state Independent Independent Home carers Family support Independent Home carers
Date of positive COVID-19 test 17/12/2020 11/12/2020 10/01/2021 23/12/2020 15/12/2020 11/01/2021
Nosocomial Y Y Y Y N Y
ICU Y N Y N Y N
ICU LOS 2 N/A 5 N/A 2 N/A
Date of death 18/12/2020 19/12/2020 21/01/2021 24/12/2020 16/12/2020 09/02/2021
HLOS 10 15 14 14 2 71
  Patient 7 Patient 8 Patient 9 Patient 10 Patient 11 Patient 12
DOA 31/12/2020 01/01/2021 07/01/2021 15/01/2021 22/12/2020 12/02/2021
Age, yrs 86 74 70 98 86 74
Sex, male/female Female Male Female Female Female Female
Comorbidities
Hypertension Y N N Y Y Y
Cardiovascular diseasse N N N N Y N
Diabetes N Y N N N N
Kidney disease Y Y Y N N N
Dementia N N N Y N N
Arthritis Y N N N N N
Admission type
Trauma N Y N N N Y
Orthopaedics Y N Y Y Y N
Reason for admission Fall Fall Fall Fall Fall Fall
Injury
Head and neck N Y N N N Y
Thorax N N N N N N
Spine N Y N N N Y
Pelvic N N N Y N N
Continued
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Interestingly, the overall inpatient mortality was 
similar between both waves, but the mortality rate of 
patients with COVID-19 was higher in the first wave (n = 
8; 20.5%), compared to the second wave (n = 12; 16%). 
Our surgical mortality in patients with COVID-19 was 
lower in the second wave with (n = 6; 13%) compared 
to first wave (n = 2; 15.4%). Doglietto et al20 evaluated 
the early surgical outcomes on patients with coronavirus 
who underwent surgery. Overall, 30- day mortality was 
shown to be significantly higher for those with COVID-19 
compared with patients without COVID-19 and is 
supported by other studies.21,22 The reasons for the lower 
mortality may be multifactorial, but with the explosion 
in research and treatment one might consider that our 
knowledge to treat COVID-19 by the second wave had 
improved.
We also looked at 16 patients (3.1%) who sustained 
a hip fracture and were COVID-19 positive. Overall, 13 
(81.3%) were probably hospital- acquired infections. The 
30- day mortality rate was 12.5% (n = 2), which differs 
from reports that have shown a higher increased risk 
of mortality of coronavirus infections in hip fracture 
patients.23,24 Overall, ten patients (62.5%) were male, 
which is in support to a nationwide study done by Hall 
et al25 on hip fractures. The study shows that the diag-
nosis of COVID-19 made between seven and 30 days of 
admission to hospital was independently associated with 
male sex.
Patients who died in the second wave were older 
(mean 75.5 years; 66 to 98), with common comorbid-
ities in the second wave compared to the first wave, 
such as hypertension (35.9% vs 46.2%), CV disease 
(16.7% vs 35.9%), and kidney disease (16.7% vs 10.3%), 
with hypertension and CV disease reported as the most 
common comorbidities.26,27 Comparing this to first wave, 
thiswas hypertension (46.2%), CV disease (35.9%), and 
arthritis (23.1%). Long hospital stay (mean 19.8 days; 2 
to 71) also increased the risk of mortality.
Overall, 75 of patients (14.4%) in our second wave 
study tested positive for COVID-19 infection versus 39 of 
patients (5.9%) in the first wave. Of these 75 patients in 
our second wave cohort, 51 (68%) had hospital acquired 
coronavirus infection (overall cohort nosocomial rate 
9.8%), which is similar to the estimated rate obtained 
during the first wave (n = 27; 69.2%).5 We previously 
made the correct assumption that asymptomatic admis-
sions were COVID-19 negative, but we also did not have 
the resources to test all admissions.
The mechanisms of viral spread between patients who 
contracted the virus while an inpatient is yet to be estab-
lished. Transmission of COVID-19 infection in healthcare 
settings has a significant implication for patients and 
healthcare workers, which may add to the burden on 
resources. Zheng et al28 reported an increase in COVID-19 
rates in healthcare workers, and showed that clinical staff 
had a higher rate of laboratory confirmed COVID-19 than 
non- clinical staff, with doctors having the highest rate 
of infection but took the fewest sickness days. Another 
possible mechanism of contamination could be through 
the movement of patients within the hospital. Of note, 
only one trauma patient admitted with COVID-19 was a 
healthcare worker.
We agree with literature that shows airborne spread is a 
significant factor other than just fomite spread by surface 
contact.29 Good ventilation became more apparent as a 
useful combat technique against spread, and was soon 
adopted by public healthcare warnings advising open 
windows to improve. There may also be a role for UV 
light and UV air filters in public domains.30 During the 
COVID-19 pandemic, preventive measures were imple-
mented at our centre to reduce the risk of contamina-
tion in hospital. Measures included mandatory wearing 
  Patient 7 Patient 8 Patient 9 Patient 10 Patient 11 Patient 12
Upper limb N N N N N N
Lower limb Y N Y N Y N
Intervention
Surgery N Y N Y Y N
Date of surgery N/A 01/01/2021 N/A 15/01/2021 03/01/2021 N/A
Conservative Y Y Y N N Y
BMI, kg/m2 26.84 25.41 25.97 18.01 26.84 Unrecorded
Ethnicity Asian White Asian White Asian White
Pre- morbid state Family support Independent Independent Supported housing Independent Independent
Date of positive COVID-19 test 13/01/2021 13/12/2020 06/02/21 15/01/2021 13/01/2021 12/02/21
Nosocomial Y N Y N Y N
ICU N N N N N Y
ICU LOS N/A N/A N/A N/A N/A 10
Date of death 19/01/2021 15/01/2021 08/02/2021 21/01/21 19/01/2021 22/02/2021
HLOS 20 15 32 6 28 10
DOA, date of admission; HLOS, hospital length of stay; ICU, intensive care unit; LOS, length of stay; N/A, not applicable.
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of masks, increased use of alcoholic prep solutions and 
hand washing, and staff training. Hospital visitors were 
also restricted and checked on entry for hand washing 
and mask use, something which was not implemented 
until September 2020. Mandatory screening of all 
patients on admission, whether or not they have symp-
toms, was also implemented by the NHS England and 
NHS Improvement on 24 June 2020.7 Patients travelling 
for tests and throughout the hospital were also given 
masks (e.g. when travelling to surgery by bed). Patient 
bed state was assigned based on patient status on admis-
sion. Elective patients were placed on 'super green' wards 
(14 days shielded and COVID-19 negative). Other admis-
sions were placed on green wards (three days shielded 
and COVID-19 negative); amber wards (low/high risk 
pending COVID-19 results); yellow wards (non- shielding 
COVID-19 negative); and blue wards (COVID-19 posi-
tive). We also used local independent hospitals, which 
maintained super green or green status for ambulatory 
trauma, reducing footfall, virtual outpatient clinics, and 
a cessation of the majority of elective surgery was well 
implemented.5
The limitations of this study include the lack of 
COVID-19 testing on admission in our first wave cohort. 
Analysis of characteristics during the second wave after 
the advent of the new UK variant were conducted on 
the basis and knowledge of its rapidly spreading exis-
tence. However, we cannot confirm which variants were 
detected in our cohort. The 80 days in both cohorts looked 
at slightly different parts of the curves, but represents 
relevant snapshots of time during the pandemic. The 
time frames chosen were based on publically announced 
major singular events; the first UK death and the first 
announcement of a new UK variant.
There was a steady admission in the second wave 
cohort with a significant (p < 0.001) Overall, 20% less 
admissions compared to the first wave cohort. There 
was a three- fold increase in COVID-19- infected patients 
in the second wave.
In support that the new UK variant was more infec-
tious, we see from our cohort during the second wave 
that surgery on COVID-19 patients was significantly 
higher (p = 0.005), with 61.3% compared to 33.3% in 
the first wave. ICU admissions of patients with COVID-19 
infection also showed a significant increase (p = 0.024) 
from 5.1% in the first wave to 20.5% in second wave. 
Furthermore, those who were infected were signifi-
cantly younger.
Overall mortality was similar between first wave 
(4.7%) and the second wave (6.1%). However, the risk 
of death with COVID-19 infections was high, with 16% 
mortality in the second wave compared to 20.5% in the 
first wave. Concomitant COVID-19 and the necessity 
of major trauma surgery showed 13% mortality in the 
second wave compared with 15.4% in the first wave. 
It is clear that COVID-19 infection is a significant risk 
factor for mortality in trauma patients regardless of 
whether they have surgery.
In contrast to the literature, we showed a high 
percentage of nosocomial infection, normal BMI, and 
limited BAME infections. There was a similar proportion 
of hospital- acquired COVID-19 infection in the first wave 
(69.2%) compared to the second wave (68%), with equal 
preponderance of males to females ratio in both groups. 
COVID-19 patients in the second wave were younger, 
with a mean age of 60 years (6 to 98) compared to the 
first wave (mean age 73 years; 28 to 98), supporting 
the greater virulence of the new variant SARS- CoV-2 VUI 
202012/01. High BMI (9.8% BMI > 30 kg/m2) and BAME 
(25%) were not significant risk factors.
During the second wave, the overall COVID-19 infec-
tion rate was 14.4% (9.8% nosocomial). If the patient 
had COVID-19, 68% were hospital- acquired, and 15.7% 
of these patients died. It will be of future importance to 
mitigate hospital- acquired infection, and will be of signif-
icant interest to evaluate how COVID-19 vaccines change 
these patient characteristics and nosocomial infection 
rates.
Take home message
  - This study describes a large cohort of major trauma and 
orthopaedic patients in a UK setting and captures the clinical 
characteristics and nosocomial infection with COVID-19 in the 
first and second wave, supporting that the new UK variant was more 
infectious as we see from our cohort during the second wave.
  - These findings will help guide future healthcare policies against 
COVID-19. It will be of future importance to mitigate hospital- acquired 
infection, and will be of significant interest to evaluate how COVID-19 
vaccines change these patient characteristics and nosocomial infection 
rates.
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